Manufactured by Swiss pharma company Roche, it will be marketed in India by Cipla, and can be used to treat mild to moderate patients and infections that are at risk of turning severe.
Hyundai was never scared of rivals overtaking them last year. But in 2027, the mythical ‘Creta Killer’ may finally emerge. Or it could continue to remain a myth.
IAF is fine with accepting the aircraft with 'must-haves', even if some other steps remain pending, which may take at least another year, it is learnt.
COMMENTS